![](/img/cover-not-exists.png)
Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors
Sue Ellen Verbrugge,Marjon Al,Yehuda G Assaraf…Volume:
2
Language:
english
Journal:
Experimental Hematology & Oncology
DOI:
10.1186/2162-3619-2-2
Date:
December, 2013
File:
PDF, 446 KB
english, 2013